Riskpilot← Back to searchSign inGet full accessNordic microbes A/S
A/SActiveCVR 42559997Kochsgade 25Research and experimental development on natural sciences and engineering · NACE 7210Est. 202120 employeeswww.bioomix.com
Revenue 2024
DKK 6,1M
+35% vs 2023
EBITDA margin
-127.0%
-54% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
DKK -6,5M
-44% vs 2023
| Revenue | DKK 6,1M | +35% |
| EBITDA | DKK -7,8M | -54% |
| Net profit | DKK -6,5M | -44% |
| Total assets | DKK 46,1M | -12% |
| Equity | DKK 44,2M | -13% |
| Employees | 20 | — |
Legal name
Nordic microbes A/S
CVR number
42559997
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. juli 2021
Share capital
DKK 481.849
Employees
20 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen sammen med en direktør.
Company purpose
Selskabets formål er at udvikle og sælge bioteknologiske produkter.
Address
Kochsgade 25
Phone
+4552114513
Email
moa@bioomix.com
Website
www.bioomix.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 3.424 | 4.542 | 6.148 |
| Staff expenses | -6.070 | -9.615 | -13.867 |
| EBITDA | -2.646 | -5.077 | -7.809 |
| Depreciation & amort. | -234 | -801 | -1.993 |
| EBIT | -2.880 | -5.878 | -9.802 |
| Net financials | -210 | -49 | 1.191 |
| Profit before tax | -3.090 | -5.927 | -8.611 |
| Tax | -929 | -1.401 | -2.088 |
| Net profit | -2.161 | -4.526 | -6.523 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 13.088 | 52.172 | 46.069 |
| Equity | 7.877 | 50.682 | 44.159 |
| Long-term debt | 4.160 | 0 | 0 |
| Short-term debt | 1.051 | 1.490 | 1.631 |
| Total debt | 5.211 | 1.490 | 1.631 |
EBITDA margin
-127.0%
This company
15.8%
Market median
-904% vs market
20222024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20222024
Return on equity
-14.8%
This company
18.4%
Market median
-180% vs market
20222024
Net profit margin
-106.1%
This company
8.1%
Market median
-1410% vs market
20222024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20222024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2021-07-23 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MØ Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Omixholding ApS | Company | 33.3% | 33.3% | 2023 |
PSV Hafnium Fund I K/S | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2024 | |
Planetary Impact Ventures Fund K/S | Company | 5.0% | 5.0% | 2023 |
PreSeed Ventures A/S | Company | 5.0% | 5.0% | 2022 |
SCIENCE VENTURES DENMARK A/S | Company | 5.0% | 5.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Omixholding ApS
Nordic microbes A/S Board members of Nordic microbes A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Østergaard Andersen | Management | 0 companies |
| Julia Magdalena Østergaard Andersen | Board of Directors | 0 companies |
| Thomas Hessellund | Chairman | 0 companies |
| Anders Peter Gram | Board of Directors | 0 companies |
| Henrik Busch-Larsen | Chairman | 0 companies |
| Niels Dengsø Jensen | Board of Directors | 0 companies |
| Christopher Jeremy Horne | Board of Directors | 0 companies |
| Anders Kjær | Board of Directors | 0 companies |